Trends in reperfusion therapy of ST segment elevation myocardial infarction in Switzerland: Six year results from a nationwide registry

Heart

Volumn 91, Issue 7, 2005, Pages 882-888

  Fassa, A A ^a   Urban, Philip ^a   Radovanovic, D ^b   Duvoisin, N ^b   Gaspoz, J M ^c   Stauffer, J C ^d   Erne, P ^e  

^a LA TOUR HOSPITAL   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e Division of Cardiology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE REPERFUSION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STATISTICAL SIGNIFICANCE; SWITZERLAND; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; CARDIOPULMONARY RESUSCITATION; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PROSPECTIVE STUDIES; REGISTRIES; SWITZERLAND; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 21044458555     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.037689     Document Type: Article

References (33)

1. Davies MJ, Woolf N, Robertson WB. Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi. Br Heart J 1976;38:659-64.
2. Chazov EI, Matveeva LS, Mazaev AV, et al. [Intracoronary administration of fibrinolysin in acute myocardial infarct]. Ter Arkh 1976;48:8-19.
3. Rentrop KP, Blanke H, Karsch KR, et al. Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase. Clin Cardiol 1979;2:354-63.
4. GISSI Investigators. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;i:397-402.
5. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2, Lancet 1988;ii:349-60.
6. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
7. Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College or Cardiology/American Heart Association task force on practice guidelines (Committee on Management Of Acute Myocardial Infarction). J Am Coll Cardiol 1999;34:890-911.
8. Van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the management of acute myocardial infarction of the European Society of Cardiology. Eur Heart J 2003;24:28-66.
9. Zahn R, Schiele R, Schneider S, for the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and the Myocardial Infarction Registry (MIR) Study Groups, et al. Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Results from the pooled data or the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR). J Am Coll Cardiol 2000;36:2064-71.
10. Danchin N, Vaur L, Genès N, et al. Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the "real world". One-year results from a nationwide French survey. Circulation 1999;99:2639-44.
11. Rogers WJ, Canto JG, Lambrew CT, et al, for the investigators in the national registry of myocardial infarction 1, 2 and 3. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999. The national registry of myocardial infarction 1, 2 and 3. J Am Coll Cardiol 2000;36:2056-63.
12. Fox KAA, Goodman SG, Anderson FA, on behalf of the GRACE Investigators, et al. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The global registry of acute coronary events (GRACE). Eur Heart J, 2003;24;1414-24.
13. Fox KAA, Cokkinos DV, Deckers J, on behalf of the ENACT (European Network for Acute Coronary Treatment) investigators, et al. The ENACT study: a pan-European survey of acute coronary syndromes. Eur Heart J 2000;21:1440-9.
14. Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro heart survey of acute coronary syndromes (Euro heart survey ACS). Eur Heart J 2002;23:1190-201.
15. Every NR, Parsons LS, Hlatky M, et al. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. N Engl J Med 1996;335:1253-60.
16. Urban P, Bernstein MS, Costanza MC, et al. An internet-based registry of acute myocardial infarction in Switzerland. Kardiovask Med 2000;3:430-40.
17. Erne P, Radovanovic D, Urban P, et al. Early drug therapy and in-hospital mortality following acute myocardial infarction. Heart Drug 2003;3:134-40.
18. Fibrinolytic Therapy Trialists' Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1,000 patients. Lancet 1994;343:311-22.
19. Zahn R, Schiele R, Gilt AK, et al. Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis. Am Heart J 2001;142:105-11.
20. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-bolloon time and door-to-bolloon time with mortality on patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283:2941-57.
21. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733-42.
22. Kannel WB, Abbott RD. Incidence and prognosis of myocardial infarction in women: The Framingham Study. In: Eaker ED, Packard B, Wenger NK, et al. Coronary heart disease in women: proceedings of an NIH workshop. New York: Haymark Doyma, 1987:208-214.
23. Weaver WD, White HD, Wilcox RG, et al. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. JAMA 1996;275:777-82.
24. Tunstall-Pedoe H, Morrison C, Woodward M, et al. Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985 to 1991. Presentation, diagnosis, treatment, and 28-day case fatality of 3991 events in men and 1551 events in women. Circulation 1996;93:1981-92.
25. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
26. Stone GW, Brodie BR, Griffin JJ, et al. Clinical and angiographic follow-up after primary stenting in acute myocardial infarction. The primary angioplasty in myocardial infarction (PAMI) stent pilot trial. Circulation 1999;99:1548-54.
27. Suryapranota H, van't Hof AWJ, Hoorntje JCA, et al. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998;97:2502-5.
28. Montalescot G, Barragan P, Wittenberg O, et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001;344:1895-903.
29. Gaspoz JM, Unger PF, Urban P, et al. Impact of a public campaign on pre-hospital delay in patients reporting chest pain. Heart 1996;76:150-5.
30. Widimsky P, Budesinsky T, Vorac D, on behalf of the "PRAGUE" study group Investigators, et al. Lang distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomised national multicentre trial-PRAGUE-2. Eur Heart J 2003;24:94-104.
31. Hermann HC, Moliterno DJ, Ohman EM, et al. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction. Results from the SPEED (GUSTO-4 pilot) trial. J Am Coll Cardiol 2000;36:1489-96.
32. Keeley EC, Cigarroa J. Facilitated primary percutaneous transluminal coronary angioplasty for acute ST segment elevation myocardial infarction: rationale for reuniting pharmacologic and mechanical revascularization strategies. Cardiol Rev 2003;11:13-20.
33. Rux S, Lenssen K, Sonntag S, et al. Low hospital and long-term mortality in a prospective registry of facilitated percutaneous coronary intervention in acute myocardial infarction. Am J Cardiol 2003;92:67-71.